外泌体在新型冠状病毒感染和传播中作用的研究进展

doi:10.16352/j.issn.1001-6325.2023.04.0680

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (4): 680-684.doi: 10.16352/j.issn.1001-6325.2023.04.0680

外泌体在新型冠状病毒感染和传播中作用的研究进展

崔诗雨^1,2, 张海峰^1,2*

西安交通大学 1.基础医学院病理学系,陕西西安 710061;
2.转化医学研究院遗传与发育研究所,陕西西安 710100

收稿日期:2022-02-11 修回日期:2022-06-05 出版日期:2023-04-05 发布日期:2023-04-03
通讯作者: ^*zhf19841011@xjtu.edu.cn
基金资助:
国家自然科学基金(81402312);中央高校基本科研业务费专项资金(xjj2018158);中国博士后科学基金(2014M552462)

Progress in the exosomes mediating SARS-CoV-2 infection and transmission

CUI Shiyu^1,2, ZHANG Haifeng^1,2*

1. Department of Pathology,Basic Medicine College, Xi'an Jiaotong University, Xi'an 710061;
2. Institute of Genetics and Developmental Biology, Translational Medicine Institute, Xi'an Jiaotong University, Xi'an 710100, China

Received:2022-02-11 Revised:2022-06-05 Online:2023-04-05 Published:2023-04-03
Contact: ^*zhf19841011@xjtu.edu.cn

摘要/Abstract

摘要： 外泌体在COVID-19的病理过程中起着重要作用,与其携带的核酸、蛋白质等物质,共同调控SARS-CoV-2的感染和传播。病毒感染细胞通过内体途径产生含SARS-CoV-2病毒颗粒的外泌体,介导病毒向健康细胞感染和传播,造成组织损伤和多器官功能障碍。同时,外泌体作为细胞间通讯的关键介质,起到免疫激活作用,促进机体产生免疫反应,抵抗病毒入侵。此外,外泌体协助病毒逃避机体免疫,是SARS-CoV-2再感染的潜在手段。总之,外泌体在新型冠状病毒感染和传播中的作用为其在诊断、防治COVID-19等方面的应用提供新思路。

关键词: 外泌体, SARS-CoV-2, COVID-19

Abstract: Exosomes play vital roles in the pathogenesis of COVID-19 infection. The infection and transmission of the disease is regulated by exosomes and their components, such as nucleic acids, proteins and other substances. The exosomes with COVID-19 particles are produced via the endosomal pathway from the infected cells, and mediate the viral infection and transmission to healthy cells, finally ending with the results of tissue damage and multiple organ dysfunctions. As the key mediators of intercellular communication, exosomes activate the immune system and enhance the response against virus invasion. In addition, COVID-19 may escape from immunity with the help of exosomes; this may be a potential way of reinfection. The role of exosomes in novel coronavirus infection and transmission provides important clues for the development of potential technology for the diagnosis and prevention.

Key words: exosomes, SARS-CoV-2, COVID-19

中图分类号:

R511

崔诗雨, 张海峰. 外泌体在新型冠状病毒感染和传播中作用的研究进展[J]. 基础医学与临床, 2023, 43(4): 680-684.

CUI Shiyu, ZHANG Haifeng. Progress in the exosomes mediating SARS-CoV-2 infection and transmission[J]. Basic & Clinical Medicine, 2023, 43(4): 680-684.

参考文献

[1]Hassanpour M, Rezaie J, Nouri M, et al. The role of extracellular vesicles in COVID-19 virus infection[J]. Infect Genet Evol, 2020,85:104422.doi:10.1016/j.meegid.2020.104422.
[2]Yuana Y, Sturk A,Nieuwland R. Extracellular vesicles in physiological and pathological conditions[J]. Blood Rev, 2013, 27: 31-39.
[3]Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018):a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines[J]. J Extracell Vesicles,2018,7:1535750.doi:10.1080/20013078.2018.1535750.
[4]Ludwig AK,Giebel B. Exosomes: small vesicles participating in intercellular communication[J]. Int J Biochem Cell Biol, 2012, 44: 11-15.
[5]Hatmal MM, Alshaer W, Al-Hatamleh MAI, et al. Comprehensive structural and molecular comparison of spike proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and their interactions with ACE2[J]. Cells, 2020,9:2638.doi:10.3390/cells9122638.
[6]Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med, 2020, 382: 1708-1720.
[7]Leng Z, Zhu R, Hou W, et al. Transplantation of ACE2 mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia[J].Aging Dis, 2020, 11: 216-228.
[8]Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycopro-tein[J]. Cell, 2020, 181:281-292.
[9]Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020, 181:271-280.
[10]Pironti G, Andersson DC,Lund LH.Mechanistic and therapeutic implications of extracellular vesicles as a potential link between Covid-19 and cardiovascular disease manifestations[J]. Front Cell Dev Biol,2021,9:640723.doi:10.3389/fcell.2021.640723.
[11]Barberis E, Vanella VV, Falasca M, et al. Circulating exosomes are strongly involved in SARS-CoV-2 infection[J].Front Mol Biosci,2021,8:632290.doi:10.3389/fmolb.2021.632290.
[12]Hong W.Combating COVID-19 with chloroquine[J]. J Mol Cell Biol, 2020, 12: 249-250.
[13]Bansal S, Tokman S, Fleming T, et al. SARS-CoV-2 infection in lung transplant recipients induces circulat-ing exosomes with SARS-CoV-2 spike protein S2[J]. Clin Transl Med, 2021, 11: e576. doi: 10.1002/ctm2.576.
[14]Kalluri R,LeBleu VS. The biology function and biome-dical applications of exosomes[J]. Science, 2020, 367:eaau6977.doi: 10.1126/science.aau6977.
[15]Wang J, Chen S,Bihl J. Exosome-mediated transfer of ACE2 (angiotensin-converting enzyme 2) from endothelial progenitor cells promotes survival and function of endothelial cell[J]. Oxid Med Cell Longev,2020,2020:4213541.doi:10.1155/2020/4213541.
[16]Su G, Ma X,Wei H. Multiple biological roles of extracellular vesicles in lung injury and inflammation microenvironment [J]. Biomed Res Int, 2020, 2020: 5608382. doi:10.1155/2020/5608382.
[17]Ikhlas S, Usman A, Kim D, et al. Exosomes/microve-sicles target SARS-CoV-2 via innate and RNA-induced immunity with PIWI-piRNA system[J]. Life Sci Alliance, 2022, 5:e202101240. doi:10.26508/lsa.202101240.
[18]Wang Y, Zhu X, Jiang XM, et al. Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients[J]. Signal Transduct Target Ther, 2021, 6:300.doi:10.1038/s41392-021-00716-y.
[19]Mishra R,Banerjea AC.SARS-CoV-2 spike targets USP33-IRF9 axis exosomal miR-148a to activate human microglia[J]. Front Immunol, 2021, 12: 656700. doi:10.3389/fimmu.2021.656700.
[20]Chutipongtanate S, Kongsomros S, Pongsakul N, et al. Anti-SARS-CoV-2 effect of extracellular vesicles released from mesenchymal stem cells[J]. J Extracell Vesicles, 2022, 11: e12201. doi:10.1002/jev2.12201.
[21]Song JW, Lam SM, Fan X, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis[J]. Cell Metab, 2020, 32:188-202.
[22]Balbi C, Burrello J, Bolis S, et al. Circulating extra-cellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection[J]. EBioMedicine, 2021, 67: 103369. doi:10.1016/j.ebiom.2021.103369.
[23]Ahmed S, Paramasivam P, Kamath M, et al. Genetic exchange of lung-derived exosome to brain causing neuronal changes on COVID-19 infection[J]. Mol Neurobiol, 2021, 58: 5356-5368.
[24]Saadaoui M, Kumar M,Khodor S. COVID-19 infection during pregnancy: risk of vertical transmission, fetal, and neonatal outcomes[J]. J Pers Med, 2021, 11:483. doi:10.3390/jpm11060483.
[25]Farkash EA, Wilson AM,Jentzen JM.Ultrastructural evidence for direct renal infection with SARS-CoV-2[J]. J Am Soc Nephrol, 2020, 31: 1683-1687.

外泌体在新型冠状病毒感染和传播中作用的研究进展

Progress in the exosomes mediating SARS-CoV-2 infection and transmission

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	于曼殊, 赵晓敏, 邱明月, 刘春冉, 那日苏. 牙源性干细胞治疗帕金森病的研究进展[J]. 基础医学与临床, 2024, 44(9): 1298-1302.
[2]	赵俊丽, 朱君君, 詹秋楠, 刘苗. 骨髓间充质干细胞来源外泌体抑制高糖诱导的腹膜间皮细胞EMT[J]. 基础医学与临床, 2024, 44(8): 1149-1156.
[3]	高璐, 蔡孟华, 许依, 何维, 陈慧, 张建民. 过表达膜定位IL-3的293T细胞外泌体的纯化及体外功能验证[J]. 基础医学与临床, 2024, 44(7): 947-953.
[4]	戴靖榕, 肖宝, 李霖, 胡江英, 刘斌. 影响老年新型冠状病毒感染患者院内死亡的因素及风险预测模型的构建[J]. 基础医学与临床, 2024, 44(1): 92-97.
[5]	颜晨红, 金儿. 外泌体PD-L1在非小细胞肺癌诊断和治疗上的研究进展[J]. 基础医学与临床, 2023, 43(9): 1457-1461.
[6]	方路, 刘睿奇, 梁鹏, 岑瑛. 外泌体miRNAs在器官纤维化中作用的研究进展[J]. 基础医学与临床, 2023, 43(9): 1472-1476.
[7]	杨雅倩, 潘艳芳, 屈梦扬, 方艳, 应小平, 张玫倩, 魏静. 外泌体在肝癌前病变发生发展中作用的研究进展[J]. 基础医学与临床, 2023, 43(9): 1453-1456.
[8]	陈星星, 赛依帕, 胡筱霞, 王三萍, 罗璇, 刘璟. 人脐带间充质干细胞来源外泌体对脑瘫小鼠神经功能损伤的保护作用[J]. 基础医学与临床, 2023, 43(8): 1201-1207.
[9]	包秋芳, 蔡琼仪, 杨惠娟, 洪琳亮. 10例新型冠状病毒奥密克戎变异株感染孕妇临床特征及新生儿结局分析[J]. 基础医学与临床, 2023, 43(7): 1134-1137.
[10]	闫霖, 陆珏秀, 罗颖, 刘先霞. BM-MSCs来源外泌体介导铁死亡减轻大鼠心肌细胞系H9c2缺氧/复氧损伤[J]. 基础医学与临床, 2023, 43(5): 771-776.
[11]	许津铭, 洪语萱, 韦晖, 许琪. 抗SARS-CoV-2相关线性表位抗体诱发小鼠神经炎性反应[J]. 基础医学与临床, 2023, 43(3): 438-443.
[12]	姚刘旭, 李玉红, 蒋宗明. 外泌体lncRNA在结直肠癌液体活检中的研究进展[J]. 基础医学与临床, 2023, 43(2): 317-321.
[13]	王亮, 司萍, 沈永明, 崔晓鸣. 中性粒细胞在COVID-19发生发展中作用的研究进展[J]. 基础医学与临床, 2023, 43(2): 341-345.
[14]	姜俣, 钱海燕. 间充质干细胞治疗心肌梗死的研究进展[J]. 基础医学与临床, 2023, 43(1): 21-29.
[15]	商利鹏, 刘国祥, 丁晓燕, 李冰, 赵春华, 李霄霞. 间充质干细胞在衰老相关疾病应用中的研究进展[J]. 基础医学与临床, 2023, 43(1): 38-45.